Lifestyle Modification in the Prevention and Treatment of Atrial Fibrillation

Progress in Cardiovascular Diseases

Volumn 58, Issue 2, 2015, Pages 117-125

  Menezes, Arthur R ^a   Lavie, Carl J ^a   De Schutter, Alban ^a   Milani, Richard V ^a   O'Keefe, James ^b   DiNicolantonio, James J ^b   Morin, Daniel P ^a   Abi Samra, Freddy M ^a  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

Atrial fibrillation; Diabetes mellitus; Hypertension; Obesity; Obstructive sleep apnea

Indexed keywords

CAFFEINE; HEMOGLOBIN A1C;

ADIPOSE TISSUE; ALCOHOL CONSUMPTION; ARTICLE; ATRIAL FIBRILLATION; BLOOD GLUCOSE MONITORING; BODY MASS; CARDIORESPIRATORY FITNESS; CYCLING; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDURANCE TRAINING; HEART ATRIUM REMODELING; HEART PROTECTION; HUMAN; HYPERTENSION; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; OBESITY; PERICARDIAL FAT; POSITIVE END EXPIRATORY PRESSURE; PREDICTOR VARIABLE; RECURRENCE RISK; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SURVIVAL; SYSTOLIC BLOOD PRESSURE; WALKING; WEIGHT REDUCTION; COMORBIDITY; LIFESTYLE; PATHOPHYSIOLOGY; PREVENTIVE HEALTH SERVICE; RECURRENT DISEASE; RISK ASSESSMENT; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; COMORBIDITY; HUMANS; LIFE STYLE; PREVENTIVE HEALTH SERVICES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 84942190953     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2015.07.001     Document Type: Article

References (103)

1. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) study. JAMA 2001, 285:2370-2375.
2. Lloyd-Jones D.M., Wang T.J., Leip E.P., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004, 110:1042-1046.
3. Colilla S., Crow A., Petkun W., et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol 2013, 112(8):1142-1147.
4. Friberg J., Scharling H., Gadsboll N., et al. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). Am J Cardiol 2003, 92:1419-1423.
5. Ruo B., Capra A.M., Jensvold N.G., et al. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. J Am Coll Cardiol 2004, 43:429-435.
6. Feinberg W.M., Blackshear J.L., Laupacis A., et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995, 155(5):469-473.
7. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22:983-988.
8. Frost L., Hune L.J., Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med 2005, 118(5):489-495.
9. Rosengren A., Hauptman P.J., Lappas G., et al. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 2009, 30(9):1113-1120.
10. Qureshi W., Soliman E.Z., Solomon S.D., et al. Risk factors for atrial fibrillation in patients with normal versus dilated left atrium (from the Atherosclerosis Risk in Communities Study). Am J Cardiol 2014, 114(9):1368-1372.
11. Vaziri S.M., Larson M.G., Benjamin E.J., Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation: the Framingham Heart Study. Circulation 1994, 89:724.
12. Zhuang J., Wang Y., Tang K., et al. Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. Europace 2012, 14(5):638-645.
13. Pritchett A.M., Jacobsen S.J., Mahoney D.W., Rodeheffer R.J., Bailey K.R., Redfield M.M. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 2003, 41:1036.
14. Gerdts E., Oikarinen L., Palmieri V., et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension 2002, 39:739-743.
15. Abed H.S., Samuel C.S., Lau D.H., et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 2013, 10(1):90-100.
16. Dušan P., Tamara I., Goran V., et al. Left ventricular mass and diastolic function in obese children and adolescents. Pediatr Nephrol 2015, 30(4):645-652.
17. Fenk S., Fischer M., Strack C., et al. Successful weight reduction improves left ventricular diastolic function and physical performance in severe obesity. Int Heart J 2015, 56(2):196-202.
18. Russo C., Jin Z., Homma S., et al. Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol 2011, 57(12):1368-1374.
19. Tsang T.S., Gersh B.J., Appleton C.P., et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002, 40(9):1636-1644.
20. Kumar P., Patel A., Mounsey J.P., et al. Effect of left ventricular diastolic dysfunction on outcomes of atrial fibrillation ablation. Am J Cardiol 2014, 114(3):407-411.
21. Al Chekakie M.O., Welles C.C., Metoyer R., et al. Pericardial fat is independently associated with human atrial fibrillation. J Am Coll Cardiol 2010, 56(10):784-788.
22. Thanassoulis G., Massaro J.M., O'Donnell C.J., et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol 2010, 3:345-350.
23. Wong C.X., Abed H.S., Molaee P., et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol 2011, 57(17):1745-1751.
24. Abed H.S., Nelson A.J., Richardson J.D., et al. Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation. Am Heart J 2015, 169(5):655-662.
25. Wanahita N., Messerli F.H., Bangalore S., et al. Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 2008, 155(2):310-315.
26. Wang T.J., Parise H., Levy D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004, 292(20):2471-2477.
27. Nyström P.K., Carlsson A.C., Leander K., et al. Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study. PLoS One 2015, 10(5):e0127111.
28. de Vos C.B., Pisters R., Nieuwlaat R., et al. Progression from paroxysmal to persistent atrial fibrillation: clinical correlates and prognosis. J Am Coll Cardiol 2010, 55:725-731.
29. Tsang T.S., Barnes M.E., Miyasaka Y., et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21years. Eur Heart J 2008, 29(18):2227-2233.
30. Thacker E.L., McKnight B., Psaty B.M., et al. Association of body mass index, diabetes, hypertension, and blood pressure levels with risk of permanent atrial fibrillation. J Gen Intern Med 2013, 28(2):247-253.
31. Pathak R.K., Middeldorp M.E., Meredith M., et al. Long-term effect of goal directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY Study). J Am Coll Cardiol 2015, 65(20):2159-2169.
32. Abed H.S., Wittert G.A., Leong D.P., et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA 2013, 310(19):2050-2060.
33. Huxley R.R., Misialek J.R., Agarwal S.K., et al. Physical activity, obesity, weight change, and risk of atrial fibrillation: the Atherosclerosis Risk in Communities study. Circ Arrhythm Electrophysiol 2014, 7(4):620-625.
34. Grundvold I., Skretteberg P.T., Liestøl K., et al. Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men. Am J Cardiol 2012, 110(3):425-432.
35. Pathak R.K., Elliott A., Middeldorp M.E., et al. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals with Atrial Fibrillation: the CARDIO-FIT study. J Am Coll Cardiol 2015, 10.1016/j.jacc.2015.06.488.
36. Pathak R.K., Middeldorp M.E., Lau D.H., et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol 2014, 64(21):2222-2231.
37. Asirvatham S.J., Kapa S. Sleep apnea and atrial fibrillation: the autonomic link. J Am Coll Cardiol 2009, 54(22):2084-2086.
38. Rosario I.C. Obstructive sleep apnea: a review and update. Minn Med 2011, 94(11):44-48.
39. Gami A.S., Hodge D.O., Herges R.M., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007, 49(5):565-571.
40. Cadby G., McArdle N., Briffa T., et al. Severity of obstructive sleep apnea is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort. Chest 2015, 10.1378/chest.15-0229.
41. Dimitri H., Ng M., Brooks A.G., et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm 2012, 9(3):321-327.
42. Rajagopalan N. Obstructive sleep apnea: not just a sleep disorder. J Postgrad Med 2011, 57(2):168-175.
43. Linz D., Schotten U., Neuberger H.R., et al. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm 2011, 8(9):1436-1443.
44. Svatikova A., Wolk R., Shamsuzzaman A.S., et al. Serum amyloid a in obstructive sleep apnea. Circulation 2003, 108:1451-1454.
45. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105:2462-2464.
46. Hartmann G., Tschop M., Fischer R., et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 2000, 12:246-252.
47. Monahan K., Brewster J., Wang L., et al. Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol 2012, 110(3):369-372.
48. Ng C.Y., Liu T., Shehata M., et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 2011, 108(1):47-51.
49. Matiello M., Nadal M., Tamborero D., et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace 2010, 12(8):1084-1089.
50. Dediu G.N., Dumitrache-Rujinski S., Lungu R., et al. Positive pressure therapy in patients with cardiac arrhythmias and obstructive sleep apnea. Pneumologia 2015, 64(1):18-22.
51. Holmqvist F., Guan N., Zhu Z., et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J 2015, 169(5):647-654.
52. Naruse Y., Tada H., Satoh M., et al. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm 2013, 10(3):331-337.
53. Li L., Wang Z.W., Li J., et al. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. Europace 2014, 16(9):1309-1314.
54. Shulka A., Aizer A., Holmes D., et al. Effect of obstructive sleep apnea treatment on atrial fibrillation recurrence. A meta-analysis. JACCCEP 2015, 1(1):41-51.
55. Menezes A.R., Lavie C.J., DiNicolantonio J.J., et al. Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies. Mayo Clin Proc 2013, 88(4):394-409.
56. Gbadebo T.D., Okafor H., Darbar D. Differential impact of race and risk factors on incidence of atrial fibrillation. Am Heart J 2011, 162(1):31-37.
57. Manolis A.J., Rosei E.A., Coca A., et al. Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. J Hypertens 2012, 30(2):239-252.
58. Psaty B.M., Manolio T.A., Kuller L.H., et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997, 96(7):2455-2461.
59. Minami M., Kobayashi Y., Toyokawa S., et al. Risk factors for new-onset atrial fibrillation during routine medical checkups of Japanese male workers. Int Heart J 2009, 50(4):457-464.
60. Conen D., Tedrow U.B., Koplan B.A., et al. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 2009, 119(16):2146-2152.
61. Grundvold I., Skretteberg P.T., Liestøl K., et al. Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study. Hypertension 2012, 59(2):198-204.
62. Thomas M.C., Dublin S., Kaplan R.C., et al. Blood pressure control and risk of incident atrial fibrillation. Am J Hypertens 2008, 21(10):1111-1116.
63. Badheka A.O., Patel N.J., Grover P.M., et al. Optimal blood pressure in patients with atrial fibrillation (from the AFFIRM Trial). Am J Cardiol 2014, 114(5):727-736.
64. Tremblay-Gravel M., White M., Roy D., et al. Blood pressure and atrial fibrillation: a combined AF-CHF and AFFIRM analysis. J Cardiovasc Electrophysiol 2015, 26(5):509-514.
65. Go O., Rosendorff C. Hypertension and atrial fibrillation. Curr Cardiol Rep 2009, 11(6):430-435.
66. Schmieder R.E., Kjeldsen S.E., Julius S., et al. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens 2008, 26(3):403-411.
67. Healey J.S., Baranchuk A., Crystal E., et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005, 45(11):1832-1839.
68. Disertori M., Barlera S., Staszewsky L., et al. Systematic review and meta-analysis: renin-angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope. Cardiovasc Drugs Ther 2012, 26(1):47-54.
69. GISSI-AF Investigators, Disertori M., Latini R., et al. Valsartan for prevention of recurrent atrial fibrillation. N Engl J Med 2009, 360(16):1606-1617.
70. Pallisgaard J.L., Lindhardt T.B., Olesen J.B., et al. Management and prognosis of atrial fibrillation in the diabetic patient. Expert Rev Cardiovasc Ther 2015, 13(6):643-651.
71. Huxley R.R., Filion K.B., Konety S., Alonso A. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 2011, 108:56-62.
72. Nichols G.A., Reinier K., Chugh S.S. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care 2009, 32(10):1851-1856.
73. Aksnes T.A., Schmieder R.E., Kjeldsen S.E., et al. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol 2008, 101(5):634-638.
74. Dublin S., Glazer N.L., Smith N.L., et al. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med 2010, 25(8):853-858.
75. Schnabel R.B., Sullivan L.M., Levy D., et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009, 373(9665):739-745.
76. Ostgren C.J., Merlo J., Råstam L., et al. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab 2004, 6(5):367-374.
77. Ettinger P.O., Wu C.F., De La Cruz C., et al. Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders. Am Heart J 1978, 95(5):555-562.
78. Menz V., Grimm W., Hoffmann J., et al. Alcohol and rhythm disturbance: the holiday heart syndrome. Herz 1996, 21(4):227-231.
79. Lowenstein S.R., Gabow P.A., Cramer J., Oliva P.B., Ratner K. The role of alcohol in new-onset atrial fibrillation. Arch Intern Med 1983, 143(10):1882-1885.
80. Sano F., Ohira T., Kitamura A., et al. Heavy alcohol consumption and risk of atrial fibrillation. The Circulatory Risk in Communities Study (CIRCS). Circ J 2014, 78(4):955-961.
81. Mukamal K.J., Tolstrup J.S., Friberg J., et al. Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study. Circulation 2005, 112(12):1736-1742.
82. Samokhvalov A.V., Irving H.M., Rehm J. Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2010, 17(6):706-712.
83. Conen D., Albert C.M. Alcohol consumption and risk of atrial fibrillation: how much is too much?. J Am Coll Cardiol 2014, 64(3):290-292.
84. Djoussé L., Levy D., Benjamin E.J., et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol 2004, 93(6):710-713.
85. Djoussé L., Levy D., Benjamin E.J., et al. Alcohol consumption and risk of incident atrial fibrillation in women. JAMA 2008, 300(21):2489-2496.
86. Menezes A.R., Lavie C.J., Milani R.V., Arena R.A., Church T.S. Cardiac rehabilitation and exercise therapy in the elderly: should we invest in the aged?. J Geriatr Cardiol 2012, 9:68-75.
87. Lavie C.J., Thomas R.J., Squires R.W., et al. Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc 2009, 84:373-383.
88. Mont L., Tamborero D., Elosua R., et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace 2008, 10(1):15-20.
89. Molina L., Mont L., Marrugat J., et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace 2008, 10:618-623.
90. Link M.S., Homoud M.K., Wang P.J., Estes N.A. Cardiac arrhythmias in the athlete: the evolving role of electrophysiology. Curr Sports Med Rep 2002, 1:75-85.
91. Khan H., Kella D., Rauramaa R., et al. Cardiorespiratory fitness and atrial fibrillation: a population-based follow-up study. Heart Rhythm 2015, [pii: S1547-5271(15)00281-7]. 10.1016/j.hrthm.2015.03.024.
92. O'Keefe J.H., Lavie C.J., Guazzi M. Part 1: potential dangers of extreme endurance exercise: how much is too much? Part 2: screening of school-age athletes. Prog Cardiovasc Dis 2015, 57(4):396-405.
93. Lavie C.J., O'Keefe J.H., Sallis R.E. Exercise and the heart-the harm of too little and too much. Curr Sports Med Rep 2015, 14(2):104-109.
94. Drca N., Wolk A., Jensen-Urstad M., et al. Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women. Heart 2015, [pii: heartjnl-2014-307145]. 10.1136/heartjnl-2014-307145.
95. Karjalainen J., Kujala U.M., Kaprio J., et al. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ 1998, 316:1784-1785.
96. Elosua R., Arquer A., Mont L., et al. Sport practice and the risk of lone atrial fibrillation: a case-control study. Int J Cardiol 2006, 108:332-337.
97. Baldesberger S., Bauersfeld U., Candinas R., et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J 2008, 29(1):71-78.
98. O'Keefe J.H., Franklin B., Lavie C.J. Exercising for health and longevity vs peak performance: different regimens for different goals. Mayo Clin Proc 2014, 89(9):1171-1175.
99. Patil H., Lavie C.J., O'Keefe J.H. Cuppa joe: friend or foe? Effects of chronic coffee consumption on cardiovascular and brain health. Mo Med 2011, 108:431-438.
100. Zeng X., Li Q., Zhang M., Wang W., Tan X. Green tea may be benefit to the therapy of atrial fibrillation. J Cell Biochem 2011, 112:1709-1712.
101. Cheng M., Hu Z., Lu X., et al. Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies. Can J Cardiol 2014, 30(4):448-454.
102. Caldeira D., Martins C., Alves L.B., et al. Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart 2013, 99(19):1383-1389.
103. Artin B., Singh M., Richeh C., Jawad E., Arora R., Khosla S. Caffeine-related atrial fibrillation. Am J Ther 2010, 17:e169-e171.